{"disease":{"id":"seizures-associated-with-lennox-gastaut-syndrome","name":"seizures associated with lennox gastaut syndrome"},"drugs":{"marketed":[{"drug_id":"rufinamide","indication_name":"Seizures associated with Lennox-Gastaut Syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Banzel","generic_name":"RUFINAMIDE","company_name":"Eisai","drug_phase":"marketed","molecular_target":"Carbonic anhydrase 5A, mitochondrial","drug_class":"rufinamide","quality_score":10,"revenue":null,"mechanism":"Banzel works by stabilizing inactivated sodium channels in the brain, reducing the frequency of seizures."},{"drug_id":"bat","indication_name":"Treatment of seizures associated with Lennox-Gastaut syndrome in patients 2 years of age and older with epilepsy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bat","generic_name":"bat","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Unknown","drug_class":"Unknown","quality_score":40,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}